Late-breaking data for Roche's BTK inhibitor fenebrutinib
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act...
Source: globenewswire.com
📰 Genentech News
Page 91 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
Strategic Collaborations and Innovation Drive Next Generation Drug Conjugates Market: North America Takes the Lead in This Rapidly Growing Sector
/PRNewswire/ -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of...
United States Laura Wood Eubulus Biotherapeutics Cellectar Biosciences Eli Lilly Legochem Biosciences
Source: prnewswire.com
New Data for Genentech's Ocrevus Show That After 10 Years of Treatment 77% of People With Relapsing Multiple Sclerosis Were Free From Disability Progression and 92% Continue to Walk Unaided | National Business
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 12, 2023--
Source: joplinglobe.com
Hemophilia Treatment Market is steadily approaching a valuation of US$ 17.92 Billion by 2032 | FMI
Due to improvements in access to healthcare services, increased knowledge, and developments in medical research, the hemophilia treatment market has grown significantly in recent years. A uncommon genetic disease called haemophilia causes chronic bleeding episodes even from mild traumas because the blood cannot clot...
United States New York Asia Pacific Drug Administration Greater New York Chamber Takeda Pharmaceutical Company
Source: pharmiweb.com
Advancing Beyond Antibody Drug Conjugates: Next Generation
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Food Allergy Is Another Looming Epidemic
Contrary to earlier advice, new research suggests introducing infants to potential allergens early may reduce risk of developing allergies to those foods
Pediatr Ann Omalizumab Xolair Ligelizumab Novartis Jeannettey Wick Office Of Pharmacy Professional Development Committee On Nutrition
Source: pharmacytimes.com
First-Ever Clinical Trial Exclusively in Black and Hispanic / Latinx People Living With Multiple Sclerosis Shows Genentech's Ocrevus Effectively Manages Disease Activity | Region
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 11, 2023--
Source: eagletribune.com
Kazia announces voluntary delisting from ASX
SYDNEY, Oct. 11, 2023 /PRNewswire/ -- Kazia Therapeutics Limited , an oncology-focused drug development company, announces its intention to de-list from the Australian Securities Exchange . ...
New South Wales United States Karen Krumeich Australian Securities Exchange Kazia Therapeutics Consequences For The Company
Source: marketscreener.com
Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the United States Patent and Trademark...
United States Brianm Culley Roche Group Exchange Commission Trademark Office Lineage Cell Therapeutics Inc
Source: marketscreener.com
Futures Pointing To Continued Strength On Wall Street
The major U.S. index futures are currently pointing to a modestly higher open on Wednesday, with stocks likely to extend the upward trend seen over the past few sessions.
Source: rttnews.com